MG-98

N/A

Report date: 2022/03/14 17:17:12
NME

Base Information

Drug NameMG-98
Drug Alias NameMG-98
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionDNA (cytosine-5)-methyltransferase 1 inhibitors
TargetsDNA (cytosine-5)-methyltransferase 1
Therapy Area/IndicationsMyelodysplastic SyndromesHead and Neck NeoplasmsCarcinoma, Renal Cell +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMirati Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMirati Therapeutics IncMgi Pharma
Active IndicationsN/A
Inactive IndicationsMyelodysplastic SyndromesHead and Neck NeoplasmsCarcinoma, Renal Cell +[4] 

Other Information

ATC CodeN/A
Related LinksN/A